Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.

Hara, Noboru

Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer. [electronic resource] - Urologic oncology Sep 2012 - 596-601 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-2496

10.1016/j.urolonc.2010.11.001 doi


Adrenocorticotropic Hormone--blood
Aged
Androgen Antagonists--administration & dosage
Antineoplastic Agents, Hormonal--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Dehydroepiandrosterone Sulfate--blood
Flutamide--administration & dosage
Goserelin--administration & dosage
Human Growth Hormone--blood
Humans
Immunoassay--methods
Insulin-Like Growth Factor I--metabolism
Logistic Models
Luteinizing Hormone--blood
Male
Middle Aged
Multivariate Analysis
Outcome Assessment, Health Care
Prospective Studies
Prostate-Specific Antigen--blood
Prostatic Neoplasms--blood
Testosterone--blood